GTC
Ghost Tree Capital’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-200,000
| Closed | -$2.37M | – | 68 |
|
|
2024
Q1 | $2.37M | Buy |
200,000
+69,964
| +54% | +$830K | 0.66% | 43 |
|
|
2023
Q4 | $1.59M | Buy |
130,036
+30,036
| +30% | +$368K | 0.52% | 35 |
|
|
2023
Q3 | $963K | Buy |
+100,000
| New | +$963K | 0.32% | 48 |
|
|
2021
Q1 | – | Sell |
-200,000
| Closed | -$3.8M | – | 49 |
|
|
2020
Q4 | $3.8M | Sell |
200,000
-150,000
| -43% | -$2.85M | 0.85% | 30 |
|
|
2020
Q3 | $4.41M | Hold |
350,000
| – | – | 1.27% | 25 |
|
|
2020
Q2 | $4.24M | Hold |
350,000
| – | – | 1.12% | 26 |
|
|
2020
Q1 | $2.68M | Sell |
350,000
-65,000
| -16% | -$497K | 0.71% | 27 |
|
|
2019
Q4 | $7.39M | Buy |
415,000
+100,000
| +32% | +$1.78M | 1.41% | 21 |
|
|
2019
Q3 | $3.65M | Buy |
315,000
+15,000
| +5% | +$174K | 0.93% | 29 |
|
|
2019
Q2 | $6.65M | Sell |
300,000
-100,000
| -25% | -$2.22M | 1.38% | 17 |
|
|
2019
Q1 | $11.4M | Sell |
400,000
-25,000
| -6% | -$716K | 2.99% | 10 |
|
|
2018
Q4 | $8.39M | Buy |
425,000
+200,000
| +89% | +$3.95M | 3.05% | 10 |
|
|
2018
Q3 | $4.98M | Buy |
+225,000
| New | +$4.98M | 1.06% | 27 |
|